
Halozyme Therapeutics has announced a global collaboration and non-exclusive license with Acumen Pharmaceuticals, providing Acumen with access to Halozyme’s Enhanze …

Halozyme Therapeutics has announced it is to cull its workforce by more than half in the wake of the news …
A round-up of pharma manufacturing developments from Ranbaxy, SemBioSys, Halozyme, Aegis Protek, Alexion and Thomson/Rondaxe. Ranbaxy Laboratories of India has …
There are more quality problems to report on the manufacturing beat this week, with recalls for Ranbaxy, Halozyme/Baxter and Sagent …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

